219 related articles for article (PubMed ID: 12815042)
1. Regulation of transforming growth factor-beta signaling by protein inhibitor of activated STAT, PIASy through Smad3.
Imoto S; Sugiyama K; Muromoto R; Sato N; Yamamoto T; Matsuda T
J Biol Chem; 2003 Sep; 278(36):34253-8. PubMed ID: 12815042
[TBL] [Abstract][Full Text] [Related]
2. Repression of Smad transcriptional activity by PIASy, an inhibitor of activated STAT.
Long J; Matsuura I; He D; Wang G; Shuai K; Liu F
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9791-6. PubMed ID: 12904571
[TBL] [Abstract][Full Text] [Related]
3. Sumoylation of Smad4, the common Smad mediator of transforming growth factor-beta family signaling.
Lee PS; Chang C; Liu D; Derynck R
J Biol Chem; 2003 Jul; 278(30):27853-63. PubMed ID: 12740389
[TBL] [Abstract][Full Text] [Related]
4. The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
Imoto S; Sugiyama K; Yamamoto T; Matsuda T
Biochem Biophys Res Commun; 2004 Jun; 319(1):275-82. PubMed ID: 15158472
[TBL] [Abstract][Full Text] [Related]
5. Activation of Smad transcriptional activity by protein inhibitor of activated STAT3 (PIAS3).
Long J; Wang G; Matsuura I; He D; Liu F
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):99-104. PubMed ID: 14691252
[TBL] [Abstract][Full Text] [Related]
6. The N domain of Smad7 is essential for specific inhibition of transforming growth factor-beta signaling.
Hanyu A; Ishidou Y; Ebisawa T; Shimanuki T; Imamura T; Miyazono K
J Cell Biol; 2001 Dec; 155(6):1017-27. PubMed ID: 11739411
[TBL] [Abstract][Full Text] [Related]
7. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
8. STRAP and Smad7 synergize in the inhibition of transforming growth factor beta signaling.
Datta PK; Moses HL
Mol Cell Biol; 2000 May; 20(9):3157-67. PubMed ID: 10757800
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of Smad3 stimulates its nuclear export during PIASy-mediated suppression of TGF-beta signaling.
Imoto S; Ohbayashi N; Ikeda O; Kamitani S; Muromoto R; Sekine Y; Matsuda T
Biochem Biophys Res Commun; 2008 May; 370(2):359-65. PubMed ID: 18384750
[TBL] [Abstract][Full Text] [Related]
10. Roles for the MH2 domain of Smad7 in the specific inhibition of transforming growth factor-beta superfamily signaling.
Mochizuki T; Miyazaki H; Hara T; Furuya T; Imamura T; Watabe T; Miyazono K
J Biol Chem; 2004 Jul; 279(30):31568-74. PubMed ID: 15148321
[TBL] [Abstract][Full Text] [Related]
11. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
12. The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling.
Itoh S; Ericsson J; Nishikawa J; Heldin CH; ten Dijke P
Nucleic Acids Res; 2000 Nov; 28(21):4291-8. PubMed ID: 11058129
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-beta/Smad signaling.
Ferrigno O; Lallemand F; Verrecchia F; L'Hoste S; Camonis J; Atfi A; Mauviel A
Oncogene; 2002 Jul; 21(32):4879-84. PubMed ID: 12118366
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory smads and tgf-Beta signaling in glomerular cells.
Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
[TBL] [Abstract][Full Text] [Related]
15. A putative protein inhibitor of activated STAT (PIASy) interacts with p53 and inhibits p53-mediated transactivation but not apoptosis.
Nelson V; Davis GE; Maxwell SA
Apoptosis; 2001 Jun; 6(3):221-34. PubMed ID: 11388671
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
17. c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads.
Akiyoshi S; Inoue H; Hanai J; Kusanagi K; Nemoto N; Miyazono K; Kawabata M
J Biol Chem; 1999 Dec; 274(49):35269-77. PubMed ID: 10575014
[TBL] [Abstract][Full Text] [Related]
18. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation.
Kim BC; Lee HJ; Park SH; Lee SR; Karpova TS; McNally JG; Felici A; Lee DK; Kim SJ
Mol Cell Biol; 2004 Mar; 24(6):2251-62. PubMed ID: 14993265
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
20. AIP4 restricts transforming growth factor-beta signaling through a ubiquitination-independent mechanism.
Lallemand F; Seo SR; Ferrand N; Pessah M; L'Hoste S; Rawadi G; Roman-Roman S; Camonis J; Atfi A
J Biol Chem; 2005 Jul; 280(30):27645-53. PubMed ID: 15946939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
